8 June 2023

EULAR Technology

What can AI do for rheum?

8 June 2023

Anti JAKS Biologics EULAR Rheumatoid Arthritis

JAKis don’t beat TNFis in high-risk patients

8 June 2023

Diagnostics Genetics

Cell by cell: the path of a new era in diagnosis and treatment

8 June 2023

Medicolegal Technology

Protecting your practice from data breaches

8 June 2023

Clinical Gastro

When prunes are not enough

8 June 2023

EULAR MTX Pregnancy

MTX is okay for sperm

5 June 2023

Anti JAKS EULAR Rheumatoid Arthritis Sjogren Syndrom

Dual JAK1/TYK2 inhibitor outperforms tofacitinib

5 June 2023

EULAR Lupus Psoriatic Athritis

JAKi fallout reaches PsA guidelines

5 June 2023

EULAR Lupus Osteoporosis

Aussie researchers at EULAR

5 June 2023

Anti JAKS EULAR Rheumatoid Arthritis

CV and cancer risks with JAKi: EULAR perspectives

1 June 2023

EULAR Osteoarthritis

Good news for OA from EULAR

1 June 2023

ARA Rheumatoid Arthritis

Australian quality standard for RA is on its way

1 June 2023

EULAR Osteoarthritis

Sliver of hope for hand OA

1 June 2023

EULAR Spondyloarthritis

EULAR refocuses on coalface patient care

1 June 2023

Biologics Medications Osteoporosis Pharmaceuticals Women

Denosumab beats alendronate on fracture risk

1 June 2023

Analgesics Clinical Medications

Burnt out and overworked GPs more likely to prescribe opioids